Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 993 (118th)

Combating Illicit Xylazine Act

openUnited States· United States Congress· EN

Introduced

28 March 2023

Last action

11 January 2024 · Committee

Status

Committee on Banking, Housing, and Urban Affairs. Hearings held.

Sponsors

Sen. Cortez Masto, Catherine [D-NV], Sen. Grassley, Chuck [R-IA], Sen. Hassan, Margaret Wood [D-NH], Sen. Risch, James E. [R-ID], Sen. Shaheen, Jeanne [D-NH], Sen. Capito, Shelley Moore [R-WV], Sen. Marshall, Roger [R-KS], Sen. Manchin, Joe, III [D-WV], Sen. Kelly, Mark [D-AZ], Sen. Rounds, Mike [R-SD], Sen. Gillibrand, Kirsten E. [D-NY], Sen. Thune, John [R-SD], Sen. Hyde-Smith, Cindy [R-MS], Sen. Brown, Sherrod [D-OH], Sen. Scott, Rick [R-FL], Sen. Wicker, Roger F. [R-MS], Sen. Klobuchar, Amy [D-MN], Sen. Rubio, Marco [R-FL], Sen. Stabenow, Debbie [D-MI], Sen. Young, Todd [R-IN], Sen. Rosen, Jacky [D-NV], Sen. Casey, Robert P., Jr. [D-PA], Sen. Britt, Katie Boyd [R-AL], Sen. Luján, Ben Ray [D-NM], Sen. Boozman, John [R-AR], Sen. Vance, J. D. [R-OH], Sen. Kaine, Tim [D-VA], Sen. Warner, Mark R. [D-VA], Sen. Tillis, Thomas [R-NC], Sen. Blumenthal, Richard [D-CT], Sen. Cantwell, Maria [D-WA]

Subjects

Discovery layer

Source updated

10 August 2026

Official sourceDownload fileView documentsShare

Summary

Combating Illicit Xylazine Act This bill criminalizes the illicit use of xylazine. (Xylazine, also known as Tranq , is a sedative that is approved for use in animals. The Drug Enforcement Administration (DEA) has reported an increase in the trafficking of fentanyl mixed with xylazine.) Specifically, the bill establishes criminal penalties for manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense, xylazine for illicit use (i.e., for use in humans) in accordance with the penalties for schedule III substances (up to 10 years imprisonment or, if death or serious bodily injury occurs, up to 15 years imprisonment, as well as criminal fines). In addition, the DEA must coordinate with the Food and Drug Administration to report on the prevalence of the illicit use of xylazine, including associated supply chains. The bill also declares the illicit use of xylazine as an emerging drug threat.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 March 2023

    Introduced

    Read twice and referred to the Committee on the Judiciary.

    Source: IntroReferral

  2. 28 March 2023

    Introduced

    Introduced in Senate

    Source: IntroReferral

  3. 11 January 2024

    Committee

    Committee on Banking, Housing, and Urban Affairs. Hearings held.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 28 March 2023

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 28 March 2023

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 28 March 2023

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.